Full Text View
Tabular View
Study Results
Related Studies
Gefitinib (Iressa) and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
This study has been completed.
Study NCT00042991   Information provided by Pediatric Brain Tumor Consortium

First Received on August 5, 2002.   Last Updated on June 13, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Brain Stem Neoplasms
Central Nervous System Neoplasms
Glioma
Nervous System Neoplasms
More general conditions related to this trial
Brain Diseases
Brain Neoplasms
Central Nervous System Diseases
Infratentorial Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Nervous System Diseases
Neuroectodermal Tumors
Interventions listed in this trial
Gefitinib
Local Irradiation
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services